Articles

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Italy
Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
Hematology Department, University and Hospital Careggi, Firenze, Italy
Department of Hematology, Azienda Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
Department of Hematology, Ospedali Riuniti di Ancona, Italy
Hematology Unit, Ospedale Papardo, Messina, Italy
Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy
Division of Hematology, Niguarda Hospital, Milan, Italy
Division of Hematology, AOU, Catania, Italy
European Institute of Oncology, Milan, Italy
SC Ematologia, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
Institute of Hematology, Catholic University, Rome, Italy
Scientific Direction, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (Pz), Italy
Ospedale Moscati Department of Hematology-Oncology, Taranto, Italy
Department of Hematology, Ciaccio-Pugliese Hospital, Catanzaro, Italy
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Italy
Hematology Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
Hematology Unit, Policlinico di Bari, Italy
Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Napoli, Italy
Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy
Hematology Unit, Infermi Hospital Rimini, Italy
Hematology, Ospedale Perugia, Italy
Hematology-Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione Pascale, IRCCS, Napoli, Italy
Division of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy
Hematology Unit, Ca’ Foncello Hospital, Treviso, Italy
Sant’Andrea Hospital – Sapienza, Rome, Italy
Department of Hematology, DISM, Azienda Sanitaria Universitaria Integrata, Udine, Italy
Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Italy
OncoHematology Unit, Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy
Hematology, IRCCS Policlinico San Matteo, Pavia, Italy
Hematology, AOU Federico II Napoli, Italy
Hematology, San Bortolo Hospital, Vicenza, Italy
Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
Hematology, Università Cattolica Sacro Cuore Campobasso, Italy
Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Italy
Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Italy
Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Italy
Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Italy
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.171355